| | | | | | | | | | |
|
|
|
|
| Dockets Entered
On November 23, 2007
|
|
|
|
|
|
|
|
|
|
|
| Docket #
|
| Title
|
|
|
|
|
|
|
| 1978N-0038
|
| Sunscreen Drug Products
|
|
|
|
|
| 1999D-2145
|
| VICH GL11 on Impurities in New Veterinary Medicinal Products
|
|
|
|
|
| 1999D-2215
|
| Impurities in New Veterinary Drug Substances
|
|
|
|
|
| 2004D-0499
|
| Compliance Policy Guide Sec. 400.210 Radiofrequency Identification Feasibility Studies and Pilot Programs for Drugs
|
|
|
|
|
| 2006D-0139
|
| International Cooperation on Harmonisation of Technical Requirements for Registration of Veterinary Medicinal Products (VICH); Draft Revised Guidance for Industry on Stability Testing of New Veterina
|
|
|
|
|
|
|
|
|
| 2006N-0168
|
| Food Labeling: Reference Daily Intakes & Daily Reference Values
|
|
|
|
|
| 2006N-0454
|
| Use of Ozone-Depleting Substances; Removal of Essential-Use Designations
|
|
|
|
|
| 2006P-0393
|
| Health Claim Petition: Barley Betafiber and Coronary Heart Disease
|
|
|
|
|
| 2007D-0310
|
| Companion to Guidance for Industry on Pharmacogenomic Data
|
|
|
|
|
| 2007D-0439
|
| Guidance for Industry on Smallpox (Variola) Infection: Developing Drugs for Treatment or Prevention
|
|
|
|
|
| 2007P-0085
|
| Adopt Regulations of General Applicability to all Food Standards that would Permit Deviations from the Requirements of the Individual Food Standards of Identity
|
|
|
|
|
| 2007P-0297
|
| Request to reconsider the failure to approve Provenge
|
|
|
|
|
| 2007P-0331
|
| Ban Use of Mercury In Medicine,UNLESS Proven Toxicologically Safe to the CGMP Standard Sufficiently Nontoxic
|
|
| |
|
| 1978N-0038
|
| Sunscreen Drug Products
|
|
|
|
|
| C 660
|
| Presperse LLC
|
| Vol #:
|
| 163
|
|
|
|
|
| EC 2670
|
| American Cancer Society
|
| Vol #:
|
| 163
|
|
|
|
|
| EC 2671
|
| TenthGate Incorporated
|
| Vol #:
|
| 163
|
|
|
|
|
| EC 2672
|
| Ms. Emily PAterson
|
| Vol #:
|
| 163
|
|
|
|
|
| EC 2673
|
| Japan Cosmetic Industry Association
|
| Vol #:
|
| 163
|
|
|
|
|
| EC 2674
|
| Cosmetech Laboratories Inc.
|
| Vol #:
|
| 163
|
|
|
|
|
| EC 2675
|
| Dr. Carolyn Ferree
|
| Vol #:
|
| 163
|
|
|
|
|
| 1999D-2145
|
| VICH GL11 on Impurities in New Veterinary Medicinal Products
|
|
|
|
|
| GDL 4
|
| Guidance
|
| Vol #:
|
| 1
|
|
|
|
|
| NAD 4
|
| FDA
|
| Vol #:
|
| 1
|
|
|
|
|
| 1999D-2215
|
| Impurities in New Veterinary Drug Substances
|
|
|
|
|
| GDL 4
|
| Guidance
|
| Vol #:
|
| 1
|
|
|
|
|
| NAD 4
|
| FDA
|
| Vol #:
|
| 1
|
|
|
|
|
| 2004D-0499
|
| Compliance Policy Guide Sec. 400.210 Radiofrequency Identification Feasibility Studies and Pilot Programs for Drugs
|
|
|
|
|
| NEC 1
|
| FDA
|
| Vol #:
|
| 1
|
|
|
|
|
| 2006D-0139
|
| International Cooperation on Harmonisation of Technical Requirements for Registration of Veterinary Medicinal Products (VICH); Draft Revised Guidance for Industry on Stability Testing of New Veterina
|
|
|
|
|
|
| |
|
|
|
| GDL 2
|
| Guidance
|
| Vol #:
|
| 1
|
|
|
|
|
| NAD 2
|
| FDA
|
| Vol #:
|
| 1
|
|
| | | | | | | | |
|
| |
|
| 2006N-0168
|
| Food Labeling: Reference Daily Intakes & Daily Reference Values
|
|
|
|
|
| EC 96
|
| Community Dialysisi Units, LLC
|
| Vol #:
|
| 1
|
|
|
|
|
| EC 97
|
| Mrs. Jamie Futterman
|
| Vol #:
|
| 1
|
|
|
|
|
| EC 98
|
| Columbia Valley Community Health
|
| Vol #:
|
| 1
|
|
|
|
|
| EC 99
|
| Ms. Eve Harmeyer
|
| Vol #:
|
| 1
|
|
|
|
|
| EC 100
|
| Mrs. Jessica Seymour
|
| Vol #:
|
| 1
|
|
|
|
|
| 2006N-0454
|
| Use of Ozone-Depleting Substances; Removal of Essential-Use Designations
|
|
|
|
|
| C 4254
|
| J. E Huddleston
|
| Vol #:
|
| 40
|
|
|
|
|
| C 4255
|
| E. A Baggett
|
| Vol #:
|
| 40
|
|
|
|
|
| 2006P-0393
|
| Health Claim Petition: Barley Betafiber and Coronary Heart Disease
|
|
|
|
|
| LET 6
|
| FDA/CFSAN
|
| Vol #:
|
| 1
|
|
|
|
|
| M 1
|
| Number not used
|
| Vol #:
|
| 1
|
|
|
|
|
| 2007D-0310
|
| Companion to Guidance for Industry on Pharmacogenomic Data
|
|
|
|
|
| C 4
|
| PFizer
|
| Vol #:
|
| 1
|
|
| |
|
| 2007D-0439
|
| Guidance for Industry on Smallpox (Variola) Infection: Developing Drugs for Treatment or Prevention
|
|
|
|
|
| GDL 1
|
| Guidance
|
| Vol #:
|
| 1
|
|
|
|
|
| NAD 1
|
| FDA
|
| Vol #:
|
| 1
|
|
|
|
|
| 2007P-0085
|
| Adopt Regulations of General Applicability to all Food Standards that would Permit Deviations from the Requirements of the Individual Food Standards of Identity
|
|
|
|
|
| C 355
|
| J. Contreras
|
| Vol #:
|
| 102
|
|
|
|
|
| 2007P-0297
|
| Request to reconsider the failure to approve Provenge
|
|
|
|
|
| EC 137
|
| Mr. George Podrasky
|
| Vol #:
|
| 1
|
|
|
|
|
| 2007P-0331
|
| Ban Use of Mercury In Medicine,UNLESS Proven Toxicologically Safe to the CGMP Standard Sufficiently Nontoxic
|
|
|
|
|
| EC 11
|
| Ms. Charla Ausman-Williams
|
| Vol #:
|
| 2
|
|
